Appointment of Vice President Clinical and Regulatory Affairs

Jan 28, 2020
Posted in: Investor updates

Home » Appointment of Vice President Clinical and Regulatory Affairs

Appointment of Vice President Clinical and Regulatory Affairs

Jan 28, 2020
Posted in: Investor updates

Imagion Biosystems announces the appointment of Oliver Steinbach PhD to the position of Vice President Clinical and Regulatory Affairs.

Read the announcement.

Imagion Biosystems Delivers Major Milestone — IND Application Lodged with U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent

January 31, 2026

Imagion Biosystems Hits Major Milestone, Submits IND Application to U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent Key Highlights: Imagion Biosystems has

Quarterly Activities Report and Appendix 4C – December 2025

January 28, 2026

Key Highlights: Manufacturing and Testing of MagSense® HER2 Imaging Agent Completed, Paving Way for IND Submission Q1 2026 Wayne State University Collaboration for MRI Optimization

Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December

December 2, 2025

Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Appointment of Vice President Clinical and Regulatory Affairs

Appointment of Vice President Clinical and Regulatory Affairs

Related Articles

Imagion Biosystems Delivers Major Milestone — IND Application Lodged with U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent

Quarterly Activities Report and Appendix 4C – December 2025

Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list